DOT sbir phase I FY23 nhtsa topic no. 23-NH1 - development of a CO2 breathing anthropomorphic test device
Ended Purchase Order Awarded Last action
- Contract number
- 6913G623P800052
- Awardee
-
X-Biomedical Inc. UEI HLKGGLN5JS65
- Awarding agency
-
Immediate Office of the Secretary of Transportation
Department of Transportation
- Obligated
- $146,930
Award facts
- Opportunity
-
- U. S. Department of Transportation Small Business Innovation Research Fiscal Year 2023 Solicitation Pre-Solicitation · 6913G623QSBIR1 · Posted Jan 4, 2023
- Contract value 100% obligated
- $146,929.62 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- PSC
- AS11 Transportation R&D Services; Surface Transportation, Public Transit, And Rail; Basic Research
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 15 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Newtown Square, PA 19073, USA
- Research
- SBIR Program Phase I Action
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Original award | $146,930 |
About this award
X-Biomedical Inc., a small disadvantaged woman-owned manufacturer specializing in medtech solutions, received a $146,929.62 Phase I award from the Department of Transportation's National Highway Traffic Safety Administration (NHTSA) under the Small Business Innovation Research (SBIR) program. The contract, awarded July 20, 2023, is reserved for small business participation and calls for the development of a CO2 breathing anthropomorphic test device—a specialized safety technology intended for child presence detection testing. The two-month effort, with an ultimate completion date of January 19, 2024, follows a firm fixed-price structure and represents X-Biomedical's entry into the DOT SBIR Topic 23-NH1 research initiative, which sought innovative safety-related technologies across multiple transportation disciplines.
This Phase I award is part of the DOT's fiscal year 2023 SBIR program, which invited small businesses to develop research solutions across four DOT agencies. X-Biomedical's contract demonstrates the company's capability in advanced medical device development; notably, the firm successfully advanced to Phase II with a subsequent $498,901.29 award in September 2024 for continued development of this child presence detection technology. The work is being performed in Newtown Square, Pennsylvania, and the phased approach allows the company to validate the feasibility and commercial potential of this specialized safety device before proceeding to full-scale development.
Quick answers
Who was awarded contract 6913G623P800052?
6913G623P800052 was awarded to X-Biomedical Inc. by Immediate Office of the Secretary of Transportation (Department of Transportation) on July 20, 2023.
How much is contract 6913G623P800052 worth?
The government has obligated $146,930 on 6913G623P800052.
Was contract 6913G623P800052 competed?
The extent of competition for 6913G623P800052 was full and open competition after exclusion of sources. The government received 15 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award